XML 114 R98.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes - Additional Information (Detail) - USD ($)
 12 Months Ended
Aug. 16, 2022
Dec. 20, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Dec. 31, 2021
Income Tax Disclosure [Line Items]              
Income tax benefit, result of CARES act of 2020           $ 10,800,000  
Valuation allowance established against deferred tax assets           7,900,000  
Tax rate differential on carrying back losses amount           $ 2,900,000  
US corporate tax rate           35.00%  
Federal tax rate     21.00% 21.00% 21.00% 21.00%  
Global minimum tax rate 15.00% 15.00%          
Period for global adjusted financial statement income 3 years            
Excise tax rate on share repurchases           1.00%  
Deferred tax asset, research and development credit carryforwards     $ 20,874,000 $ 78,450,000      
Deferred tax benefit recorded as an adjustment to other comprehensive (loss) income     200,000 300,000      
Deferred tax assets, gross     98,096,000 76,699,000      
Valuation allowance established against deferred tax assets     110,960,000 86,567,000      
Valuation allowance related to foreign tax assets     24,000,000        
Increase in valuation allowance     24,400,000        
Foreign and domestic loss carry-forwards, research and development tax credits, unamortized research and development cost and state credit carry-forwards     $ 140,000,000 135,100,000      
Operating loss carry forwards expiration year     2040        
Deferred tax assets     $ 71,078,000 94,915,000      
Cash and cash equivalents     77,567,000 87,167,000      
Withholding tax liabilities in jurisdiction     400,000 400,000      
Income tax benefit (expense) from stock options exercised adjustment to equity     0 0 $ 0    
Unrecognized tax benefits     252,000 989,000 17,885,000   $ 17,836,000
Unrecognized tax benefits, effective tax rate     300,000 1,000,000 17,900,000    
Accrued interest and penalties     0 100,000 $ 100,000    
Foreign Subsidiaries [Member]              
Income Tax Disclosure [Line Items]              
Cash and cash equivalents     $ 54,200,000 $ 73,000,000      
Short-term liquidity, in percentage     78.00% 88.00%      
Operating Losses Expiration Between 2025 and 2045 [Member]              
Income Tax Disclosure [Line Items]              
Deferred tax assets     $ 27,700,000        
Minimum [Member]              
Income Tax Disclosure [Line Items]              
Average adjusted financial statement income $ 1,000,000,000            
Operating loss carry forwards expiration year     2025        
Maximum [Member]              
Income Tax Disclosure [Line Items]              
Operating loss carry forwards expiration year     2045        
Domestic [Member]              
Income Tax Disclosure [Line Items]              
Deferred tax assets, gross     $ 15,417,000 $ 101,120,000      
Valuation allowance established against deferred tax assets     87,030,000 84,767,000      
Current valuation allowance established against deferred tax assets     87,000,000        
Deferred tax assets     $ 102,447,000 $ 16,353,000